Why the study?
Ablation of ventricular tachycardia remains challenging with limited efficacy using traditional thermal energy, and pulsed field ablation may offer advantages in ventricular arrhythmias.
Does focal pulsed field ablation improve VT non-inducibility and safety in patients with ischemic cardiomyopathy and monomorphic ventricular tachycardia?
Population
5 male patients with ICM and LVEF <40% referred for MMVT ablation
Comparison
Monopolar biphasic focal pulsed field ablation
Design
Prospective case series
Follow-up
48h
Authors
Loading...
Focal PFA may support acute feasibility and safety in ischemic VT; leaves open long-term durability and efficacy.
Does focal pulsed field ablation improve VT non-inducibility and safety in patients with ischemic cardiomyopathy and monomorphic ventricular tachycardia?
Focal pulsed field ablation for ventricular tachycardia in ischemic cardiomyopathy appears acutely feasible and safe, though long-term durability remains to be established.
Alothman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: